The new antirheumatic drug Ketoprofen (Alrheumun) demonstrated good activity and tolerance in 100 outpatients with inflammatory conditions. Most patients experienced no side effects, with minimal treatment interruptions due to adverse events.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: